Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/3936Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shamshad M Shaik | - |
| dc.date.accessioned | 2026-05-12T06:13:16Z | - |
| dc.date.available | 2026-05-12T06:13:16Z | - |
| dc.date.issued | 2026-05-12 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/3936 | - |
| dc.description | Vol 62, No. 4, 229 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Antioxidants | en_US |
| dc.subject | Gavaging | en_US |
| dc.subject | Beurotoxicity | en_US |
| dc.subject | Neurotransmitters | en_US |
| dc.title | Magesium oxide nanoparticles administered orally promote degenerative changes and dysfunctioning in the brain | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol 62, No. 4, 2024 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.